Status:
COMPLETED
Cross-over Study to Investigate Retinal Function Following Administration of a Single Dose of AZD9056
Lead Sponsor:
AstraZeneca
Conditions:
Rheumatoid Arthritis
Eligibility:
MALE
18-65 years
Phase:
PHASE1
Brief Summary
The purpose of the study is to determine whether treatment with a single 800mg dose of AZD9056, a medication which has been developed as a possible treatment for Rheumatoid Arthritis, has an effect on...
Eligibility Criteria
Inclusion
- Volunteers must be able to undergo the Electroretinography assessments
- Volunteers must have an intra ocular pressure of less than 25mmHg and 6/6 vision
Exclusion
- Volunteers must pass a test that assesses whether they are at risk of narrow angle glaucoma
- Volunteers must not a family history of colour blindness, they must also pass a colour blindness test
- Volunteers must not have a history or current neurological or opthalmological (eye) disease
Key Trial Info
Start Date :
June 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2008
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT00700986
Start Date
June 1 2008
End Date
August 1 2008
Last Update
December 1 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Nottingham, Nottinghamshire, United Kingdom